Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.82B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.71B |
| 3 |
Microsoft
MSFT
|
+$1.64B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Amazon
AMZN
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$558M |
| 2 |
Occidental Petroleum
OXY
|
+$162M |
| 3 |
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
|
+$146M |
| 4 |
Extra Space Storage
EXR
|
+$142M |
| 5 |
First Horizon
FHN
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.9% |
| 2 | Financials | 13.12% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Healthcare | 10.95% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNR
2026
DELISTED
Denbury Resources, Inc.
DNR
| $5.75M | ﹤0.01% |
4,641,442
+1,244,196
| +37% | +$2.26M |
|
2027
Enovis
ENOV
$1.42B
| $5.74M | ﹤0.01% |
118,999
+18,916
| +19% | +$911K |
|
|
KALV
2028
DELISTED
KalVista Pharmaceuticals
KALV
| $5.73M | ﹤0.01% |
258,673
-55,118
| -18% | -$1.29M |
|
|
AKRX
2029
DELISTED
Akorn Inc
AKRX
| $5.72M | ﹤0.01% |
1,110,960
-182,670
| -14% | -$703K |
|
2030
Wabash National
WNC
$505M
| $5.7M | ﹤0.01% |
350,553
+65,203
| +23% | +$960K |
|
|
ARDC
2031
Are Dynamic Credit Allocation Fund
ARDC
$298M
| $5.69M | ﹤0.01% |
376,252
-24,497
| -6% | -$370K |
|
|
HSBC.PRA
2032
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
| $5.65M | ﹤0.01% |
215,651
+3,270
| +2% | +$85.3K |
|
2033
Buckle
BKE
$2.37B
| $5.64M | ﹤0.01% |
326,109
+7,672
| +2% | +$135K |
|
2034
Marcus Corp
MCS
$884M
| $5.64M | ﹤0.01% |
171,173
-384,895
| -69% | -$14.1M |
|
|
MCR
2035
DELISTED
MFS Charter Income Trust
MCR
| $5.64M | ﹤0.01% |
691,975
+75,183
| +12% | +$598K |
|
2036
Ingredion
INGR
$6.6B
| $5.63M | ﹤0.01% |
68,199
+22,718
| +50% | +$1.95M |
|
|
HIBB
2037
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $5.62M | ﹤0.01% |
308,710
+2,500
| +0.8% | +$52.5K |
|
2038
TherapeuticsMD
TXMD
$24M
| $5.6M | ﹤0.01% |
43,105
+41,790
| +3,178% | +$7.49M |
|
2039
Sonida Senior Living
SNDA
$1.84B
| $5.6M | ﹤0.01% |
74,237
+1,308
| +2% | +$82.3K |
|
|
ACIA
2040
DELISTED
Acacia Communications Inc
ACIA
| $5.6M | ﹤0.01% |
118,696
+81,899
| +223% | +$4.31M |
|
2041
Home BancShares
HOMB
$6.22B
| $5.56M | ﹤0.01% |
288,709
+656
| +0.2% | +$12.2K |
|
2042
LCI Industries
LCII
$2.61B
| $5.56M | ﹤0.01% |
61,749
-4,527
| -7% | -$400K |
|
2043
Installed Building Products
IBP
$6.63B
| $5.56M | ﹤0.01% |
93,818
+44,380
| +90% | +$2.34M |
|
|
CEO
2044
DELISTED
CNOOC Limited
CEO
| $5.55M | ﹤0.01% |
32,576
-7,112
| -18% | -$1.24M |
|
|
BGB
2045
Blackstone Strategic Credit 2027 Term Fund
BGB
$507M
| $5.54M | ﹤0.01% |
377,975
-133,097
| -26% | -$1.93M |
|
|
MSGN
2046
DELISTED
MSG Networks Inc.
MSGN
| $5.53M | ﹤0.01% |
266,699
+163,679
| +159% | +$3.59M |
|
2047
United Fire Group
UFCS
$1.39B
| $5.53M | ﹤0.01% |
114,084
-224,512
| -66% | -$10.3M |
|
|
WPX
2048
DELISTED
WPX Energy, Inc.
WPX
| $5.5M | ﹤0.01% |
478,067
+147,599
| +45% | +$1.83M |
|
|
PTLA
2049
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.49M | ﹤0.01% |
202,442
-788
| -0.4% | -$24.7K |
|
2050
BioCryst Pharmaceuticals
BCRX
$2.64B
| $5.48M | ﹤0.01% |
1,446,732
+563,822
| +64% | +$3.39M |
|
Similar funds
Invesco's Q2 2019 Portfolio in Review
As of Q2 2019, Invesco held 3,862 positions worth $389B, up 31% from $297B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco deployed $79.9B of net new capital in Q2 2019, opening 155 new positions and adding to 1,882 existing holdings. Its largest new stake was Invesco Russell 1000 Dynamic Multifactor ETF: 26,959,288 shares worth $801M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Anadarko Petroleum, an estimated $558M trimmed.
- Invesco's largest Q2 2019 buy was Invesco Russell 1000 Dynamic Multifactor ETF: 26,959,288 shares worth $801M.
- Invesco added most to Alibaba in Q2 2019, an estimated $3.82B increase.
- Invesco's biggest Q2 2019 reduction was Anadarko Petroleum, cutting an estimated $558M.
- Invesco fully exited Invesco S&P 500 GARP ETF in Q2 2019, selling an estimated $124M.
- Invesco's ten largest holdings make up 17% of its $389B portfolio in Q2 2019.
- Invesco opened 155 new positions and closed 151 in Q2 2019.
- Invesco's portfolio value rose 31% quarter-over-quarter to $389B.
Based on Invesco's 13F filing for Q2 2019, filed 14 Aug 2019.